The Hair Loss Encyclopedia
clinical trial for baricitinib treating alopecia areata
BRAVE-AA1 is a clinical trial designed to evaluate the efficacy and safety of a medication called baricitinib for treating alopecia areata, an autoimmune condition that causes hair loss. The trial aims to determine how well baricitinib, a Janus kinase (JAK) inhibitor, can help regrow hair in individuals with this condition.